|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Amyloid ß Toxic Oligomer ELISA Assay | Anti-Spermatoza (Serum) ELISA | Anti-Trastuzumab (Herceptin®) ELISA | Gd-IgA1 (Galactose-deficient IgA1) ELISA | T3 (Free) ELISA Assay |
| Citations | | | | | |
| Catalog Number | 27709 | IB79154 | TM09015 | 27600 | IB19105N |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Solid phase sandwich enzyme-linked immunosorbent assay (ELISA) for the determination of Amyloid ß Toxic Oligomer in cerebrospinal fluids. For research use only, not for use in diagnostic procedures. | Enzyme linked immunosorbent assay (ELISA) for the determination of antibodies directed against human spermatozoa in serum. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Trastuzumab (Herceptin®, Herclon®) in serum and plasma. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the pathogenesis and progression of IgA nephropathy (IgAN) in recent studies. It has been suggested that several O-link glycans-modified regions exist in the heavy chain hinge region of human IgA1 molecule and Gd-IgA1 circulates in the bloodstream of test samples with the pathological condition of IgAN.... Read More | Solid phase competitive enzyme immunoassay (ELISA) for the determination of free Triiodothyronine (fT3) in human serum. FDA exempt, can be used for in-vitro diagnostics. |
| Detection Target | Metanephrine / Normetanephrine | Anti-Spermatoza | Ranibizumab (Lucentis®) (mAb-based) | Metanephrine / Normetanephrine | Amyloid Beta (1-38) (FL) |
| Sample Type | Urine | Serum | Aqueous humour | Urine | CSF, Cell Culture Supernatant |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 3.13 to 200.0 pg/mL | 31 to 250 U/mL | 0 / 30 - 1000 ng/mL | 1.56 to 100.0 ng/mL | 1.2 to 18 pg/mL |
| Sensitivity | Metanephrine: 13 ng/mL; Normetanephrine: 23 ng/mL. | Limit of Detection (LoD): 8.553 U/mL | 0.33 ng/mL | Metanephrine: 13 ng/mL; Normetanephrine: 23 ng/mL. | 1.28 pg/mL |
| Assay Time | 1 hr 30 mins (incubation) | 2 hrs (incubation) | 2 hours, 15 min. total incubation time. | 2 hours (incubation) | 1 hr 15 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |